Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Pathologica ; 111(1): 37-40, 2019 Mar.
Article in English | MEDLINE | ID: mdl-31217621

ABSTRACT

An extremely rare renal hybrid tumor composed of papillary renal cell carcinoma (PRCC) and renal oncocytoma (RO) within the same tumor is described. Only eight previous cases are documented in the literature.A 44-year-old man showed a 3.5 cm renal mass composed by areas with tubulo-papillary structures made up with small cells with scanty cytoplasm adjacent to polygonal cells forming solid sheet and tubules with abundant eosinophilic cytoplasm and uniform, round central nuclei without mitoses. Complete immunohistochemical panel suggested a diagnosis of type 1 PRCC combined with RO. Contrary to previous cases of hybrid renal tumors reported in the literature, no pseudocapsule divided the two histotypes of tumors. Our patient is the youngest among the previous reports being 44.Collision tumours have previously been described, although mixed renal tumours composed of oncocytoma and PRCC is extremely rare. There is no evidence to suggest a relationship between oncocytoma and papillary RCC since they originate from different cells and have different prognoses.Given the possibility of oncocytomas to harbour other tumours, we suggest careful examination of the samples to exclude the presence of an associated malignant neoplasm, which might have a significantly worse prognosis than oncocytoma. Differential diagnosis is needed, and immunohistochemical stains are of great help in distinguishing between the two histological components.


Subject(s)
Adenoma, Oxyphilic , Carcinoma, Renal Cell , Kidney Neoplasms , Neoplasms, Multiple Primary , Adenoma, Oxyphilic/diagnosis , Adenoma, Oxyphilic/pathology , Adult , Carcinoma, Renal Cell/diagnosis , Carcinoma, Renal Cell/pathology , Diagnosis, Differential , Humans , Immunohistochemistry , Kidney Neoplasms/diagnosis , Kidney Neoplasms/pathology , Male , Prognosis
2.
Reumatismo ; 70(3): 133-145, 2018 Oct 03.
Article in English | MEDLINE | ID: mdl-30282439

ABSTRACT

The presence of muscular symptoms is common in rheumatological clinical practice, but often the differential diagnosis between muscular involvement in connective tissue diseases, vasculitis and drug-induced myopathy may be difficult. In addition to clinical assessment, laboratory analysis and instrumental examinations, muscle biopsy may help to clarify the diagnosis in patients with muscular involvement. The purpose of this review is to provide a critical analysis of the current medical literature on muscular histopathology, to help clinicians to identify when to perform muscular biopsy and to provide a practical guide to a better understanding of the pathology report. Moreover, we provide an overview of the muscular involvement and the most common histopathological findings in rheumatic diseases.


Subject(s)
Connective Tissue Diseases/pathology , Muscle, Skeletal/pathology , Adrenal Cortex Hormones/adverse effects , Adrenal Cortex Hormones/therapeutic use , Biopsy , Cyclosporine/adverse effects , Diagnosis, Differential , Humans , Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects , Immunoenzyme Techniques , Immunohistochemistry/methods , Muscular Diseases/chemically induced , Muscular Diseases/pathology , Penicillamine/adverse effects , Rheumatic Diseases/diagnosis , Rheumatic Diseases/pathology , Staining and Labeling/methods , Vasculitis/diagnosis
3.
Dig Liver Dis ; 39(11): 1031-4, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17317343

ABSTRACT

Biliary adenoma is a rare tumour characterized by the proliferation of bile duct epithelium into the lumen. Diagnosis is usually based on the imaging findings of bile duct dilatation and intraductal mass. We describe previously un-reported magnetic resonance imaging and magnetic resonance cholangiography features with endoscopic retrograde cholangiography and pathologic correlation of a solitary hilar biliary adenoma.


Subject(s)
Adenoma, Bile Duct/diagnosis , Bile Duct Neoplasms/diagnosis , Bile Ducts, Intrahepatic/pathology , Cholangiopancreatography, Magnetic Resonance , Magnetic Resonance Imaging , Adenoma, Bile Duct/pathology , Aged , Bile Duct Neoplasms/pathology , Cholangiography , Cholangiopancreatography, Endoscopic Retrograde , Female , Humans
4.
J Endocrinol Invest ; 29(3): 248-51, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16682839

ABSTRACT

An association between thyroid autoimmunity and breast cancer (BC) has been consistently reported, but the cause of this association is still unknown. The role of lymphocytic infiltration (LI) in breast tumorigenesis is controversial and several data suggest that in BC an increase of lymphoid cell infiltrates or a dysfunctional local immune response may be detected very early during tumor development. Chronic autoimmune thyroiditis is characterized by different degrees of LI in thyroid gland and BC cells share some antigenic properties similar to those detected in thyroid tissue, such as sodium iodide symporter (NIS) and peroxidase activity. The aim of this study was to evaluate the frequency and amount of LI in malignant and in normal peritumoral breast tissues, as expression of autoimmune morphological changes, in a group of BC patients with thyroid autoimmunity. We suppose that an increased LI in breast tissues of this group of patients may help explain the association between BC and thyroid autoimmunity. The study group included 26 BC patients with thyroperoxidase antibodies positivity (TPOAb+), 14 of them (53.8%) with Hashimoto's thyroiditis (HT), and 30 BC patients with no evidence of thyroid autoimmune disorders. Malignant and surrounding normal breast tissues were assessed for LI. The amount of LI was scored as very scanty or scanty (LI S) and moderate or marked (LI M), independently by two expert pathologists. LI S was detected in 19/26 (73.1%) BC tissues from patients with TPOAb positivity and LI M in 7 (26.9%). All BC patients with HT had LI S. LI S was detected in 25/30 (83%) and LI M in 5/30 (17%) of BC tissue from patients with no thyroid autoimmunity. The difference in the amount of LI of BC tissues in patient with or without autoimmune thyroid disorders was not significant. The LI was generally absent or very scanty in remote breast tissue in all cases. In conclusion, in breast malignancies the presence of humoral and/or clinical evidence of thyroid autoimmunity is not associated to autoimmune morphological changes of cancer and peritumoral normal tissue. The LI does not seem to have any role in tumorigenesis in patients with BC and thyroid autoimmunity.


Subject(s)
Autoimmune Diseases/complications , Breast Neoplasms/complications , Lymphocytes/pathology , Thyroid Diseases/immunology , Adult , Aged , Aged, 80 and over , Autoantibodies/blood , Breast Neoplasms/pathology , Female , Hashimoto Disease/complications , Hashimoto Disease/pathology , Humans , Middle Aged , Thyroid Diseases/complications , Thyroid Gland/immunology , Thyroid Gland/pathology
5.
J Endocrinol Invest ; 28(3): 280-4, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15952415

ABSTRACT

We report a case of acute hepatitis of autoimmune origin which occurred in a 43-yr-old woman during iv glucocorticoid (GC) pulse therapy for Graves' ophthalmopathy (GO). Prior to therapy, liver function tests were normal with no previous history of liver disorders or conditions predisposing to GC-associated liver damage. After the administration of a 4.7-g cumulative dose of methylprednisolone acetate, there was a marked increase of liver enzymes, prompting immediate discontinuation of iv GC. Nevertheless, liver enzymes increased further, reaching a peak 45 days later, with values 30- to 50-fold greater than those prior to therapy, associated with evidence of impaired liver function. Liver biopsy showed a marked lymphocytic infiltration, likely indicating an autoimmune hepatitis. Based on the assumption that following GC-induced immune suppression, autoimmune hepatitis might have been precipitated by sudden re-activation of the immune system during interpulse periods, we treated the patient with im and then oral GC, in order to re-induce immune suppression. Within three days from re-institution of GC therapy, there was a marked reduction of liver enzymes and amelioration of liver function. Complete normalization was achieved two months later, while the patient was still receiving a low maintenance dose of oral prednisone.


Subject(s)
Glucocorticoids/adverse effects , Glucocorticoids/therapeutic use , Graves Disease/complications , Graves Disease/drug therapy , Hepatitis, Autoimmune/etiology , Adult , Anti-Inflammatory Agents/adverse effects , Anti-Inflammatory Agents/therapeutic use , Body Mass Index , Female , Graves Disease/radiotherapy , Humans , Liver/enzymology , Liver/pathology , Liver Function Tests , Lymphocytes/physiology , Methylprednisolone/adverse effects , Methylprednisolone/therapeutic use , Prednisone/therapeutic use
6.
Thyroid ; 10(1): 19-23, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10691309

ABSTRACT

Codon 61 of the N-ras oncogene was screened for mutations in 99 surgically resected thyroid carcinomas by a polymerase chain resection (PCR)-based method (PCR-primer introduced restriction with enrichment of mutant alleles [PCR-PIREMA]). A point mutation of the N-ras oncogene at the codon 61 was detected in 16 of 99 (16.2%) thyroid carcinomas examined by this method. No RAS alteration was detected in the group of 11 medullary thyroid carcinomas, while 3 of 31 (10.0%) papillary carcinomas, 2 of 5 (40%) follicular carcinomas, 8 of 44 (18.2%) poorly differentiated carcinomas, and 3 of 5 (60%) undifferentiated carcinomas showed an activation of N-RAS proto-oncogene. Interestingly, two primary follicular tumors and their corresponding bone metastases, showed N-ras mutations. In the same cases we evaluated the expression of thyroglobulin by immunohistochemical analysis. Although the majority of well-differentiated carcinomas expressed a high level of thyroglobulin, the expression of the same antigen was absent or only occasional weakly positive in 33 of 44 poorly differentiated carcinomas. Interestingly, N-ras mutation was restricted to the group of tumours with low or absent thyroglobulin expression, suggesting that this genetic change is prevalent in less differentiated tumors.


Subject(s)
Carcinoma/genetics , Carcinoma/pathology , Genes, ras/genetics , Point Mutation , Thyroid Neoplasms/genetics , Thyroid Neoplasms/pathology , Bone Neoplasms/secondary , Codon , Humans , Immunohistochemistry , Nucleic Acid Hybridization , Point Mutation/genetics , Polymerase Chain Reaction/methods , Proto-Oncogene Mas , Thyroglobulin/metabolism
7.
J Clin Endocrinol Metab ; 82(12): 4094-100, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9398720

ABSTRACT

A human anaplastic thyroid cancer cell line FB-1, derived from a 68-yr-old woman who underwent surgery for anaplastic thyroid cancer, has been established. The spindlelike cells have been proliferating stably for more than 2 yr. Karyotype analysis shows many abnormalities and many marker chromosomes have been observed. Heterotransplant of FB-1 cells into severe combined immunodeficient mice has resulted in rapidly growing tumors classified as anaplastic carcinomas, although 50% have shown areas with a trabecular pattern. FB-1 cells failed to express messenger RNA for thyroglobulin; TSH-receptor; thyroperoxidase, and placental angiogenic growth factor. Conversely, PAX8 and thyroid transcription factor 1, whose expression is thyroid specific, was kept in an FB-1 cell line at a level comparable with that observed in normal thyroid tissue. In addition, the present cell line expressed high levels of messenger RNA for high-mobility group proteins (Y) and -C. The in vitro study revealed that FB-1 cells are able to produce high levels of interleukin (IL)-8 and medium amount of IL-6, whereas no release of IL-1-alpha, IL-1-beta, and IL-4 was observed. No modulation of cell proliferation and DNA synthesis in FB-1 cells has been observed after the addition of exogenous IL-6.


Subject(s)
Carcinoma/metabolism , Cytokines/biosynthesis , Thyroid Neoplasms/metabolism , Tumor Cells, Cultured/metabolism , Aged , Animals , Biomarkers , Carcinogenicity Tests , Carcinoma/pathology , Cell Differentiation/physiology , Cell Division/drug effects , Cell Separation , Cell Transformation, Neoplastic , Cytokines/pharmacology , Female , Growth Substances/pharmacology , Humans , Karyotyping , Mice , Mice, SCID , RNA, Messenger/metabolism , Thyroid Gland/cytology , Thyroid Neoplasms/pathology
8.
Neuromuscul Disord ; 4(4): 381-6, 1994 Jul.
Article in English | MEDLINE | ID: mdl-7981595

ABSTRACT

Myocardial involvement is frequently present in Xp21-linked muscular dystrophy, due to a lack of dystrophin in cardiac fibres. We describe a 41-yr-old man affected by dilated cardiomyopathy with sporadic episodes of myoglobinuria induced by effort and increased levels of serum creatine kinase. Very mild signs of skeletal myopathy were clinically evident. His mother was affected by an indefinite cardiopathy and suddenly died when she was 36 yr old. Muscle biopsy of the patient showed a dystrophic process. Dystrophin analysis together with a genetic DMD locus study led us to diagnose Becker type muscular dystrophy, with truncated dystrophin and a gene deletion extending from exon 45 to 48. Prevalent cardiac involvement in a Becker type mutation of the dystrophin gene further confirms clinical variability of dystrophinopathies.


Subject(s)
Cardiomyopathy, Dilated/genetics , Dystrophin/genetics , Muscular Dystrophies/genetics , Mutation , Adult , Biopsy , DNA/genetics , Dystrophin/metabolism , Fluorescent Antibody Technique , Gene Deletion , Genome , Humans , Male , Muscles/metabolism , Muscles/pathology , Muscular Dystrophies/metabolism , Muscular Dystrophies/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...